Stephen J Rossi is a high-level professional, that works in Pliant Therapeutics main office of which is in 1092. as a Vice President Clinical Development from 2020. This expert gained professional experience in more than 12 positions at different companies. Stephen J Rossi went to the University of California, San Francisco and received education there from 1986 to 1990. San Francisco, California is the city, where the professional was known to be situated. The person's contacts are easily accessed through Connexy by request.
Name variants:
Steven Rossi,
Stephan Rossi,
Steffan Rossi,
Stefan Rossi,
Steve Rossi,
Stevie Rossi,
Steph Rossi,
Steff Rossi,
Stef Rossi,
Steffl Rossi
Contact Information
Last Update
Jul 8, 2022
Email
ro**@gmail.com, sr**@ngmbio.com, pa**@netscape.net
Location
San Francisco, CA
Company
Pliant Therapeutics
Workplace
Vice President Clinical Development
Work History
Vice President Clinical Development
260 Littlefield Ave, South San Francisco, CA 94080
from Jul 2020
Vice President, Early Clinical Development
7575 Gateway Blvd SUITE 110, Newark, CA 94560
from Oct 2018
Senior Director, Clinical Research and Medical Affairs at Ngm Biopharmaceuticals
333 Oyster Point Blvd, South San Francisco, CA 94080
Nov 2013 — Oct 2018
Senior Director, Clinical Research - Liver Disease Therapeutics
333 Lakeside Dr, Foster City, CA 94404
Oct 2010 — Feb 2013
Director, Transplant Research and Therapeutics
Jul 1994 — Jul 1996
Transplant Immunopharmacology Fellowship
1991 — 1994
Education
1986 — 1990
1983 — 1986
Occupations
Executive
Vice President
Scientist
Biotechnology Professional
Chief Executive
Biologist
Biological Scientist
Skills
Medical Affairs
Clinical Trials
Biotechnology
Pharmacology
Virology
Clinical Development
Molecular Diagnostics
Drug Development
Protocol
Clinical Research
Medical Education
Medical Devices
Transplant
Phase 1
Clinical Study Design
Hcv
Hepatology
Phase 2
Medical Writing
Ind
Therapeutic Areas
Biopharmaceuticals
Cro
Fda
Gastroenterology
Biomarkers
Phase 3
Clinical Pharmacology
Pharmaceutical Industry
U.s. Food and Drug Administration
Orphan Drugs